NCT00459901View on ClinicalTrials.gov

Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Erlotinib and capecitabine

Trial Locations (1)

10003

Beth Israel Medical Center, New York

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

Genentech, Inc.

INDUSTRY

lead

Peter Kozuch

OTHER